FILTER

Refine your search with the following facets to narrow down your results.

15 Current news of Celgene

Evotec and Celgene further expand iPSC collaboration

06-Jun-2019 - Evotec SE announced that its strategic alliance with Celgene Corporation (“Celgene”) has been expanded to include a new cell type triggering a payment of $ 9.0 m to Evotec. Evotec and Celgene initiated the collaboration in December 2016 to identify disease-modifying treatments for a broad range ...

neurodegenerative diseases

Evotec and Celgene expand iPSC collaboration to include additional cell lines

12-Oct-2018 - Evotec AG announced that the Company will receive a $ 6 m payment from Celgene following Celgene’s decision to expand the collaboration to include additional cell lines. Evotec and Celgene initiated the collaboration in December 2016 to identify disease-modifying treatments for a broad range of ...

Celgene cell lines Evotec +1

Evotec and Celgene enter partnership in the field of targeted protein degradation

07-Sep-2018 - Evotec AG announced that Evotec and Celgene Corporation have entered into a third long-term strategic drug discovery and development partnership in the field of targeted protein degradation. In this collaboration, Evotec and Celgene will leverage Evotec's Panomics platform in order to identify ...

Celgene Evotec protein degradation +2

Evotec and Celgene expand iPSC collaboration to include additional cell lines

31-May-2018 - Evotec AG announced that the Company will receive a $ 6 m payment from Celgene following Celgene’s decision to expand the collaboration to include additional cell lines. Evotec and Celgene initiated the collaboration in December 2016 to identify disease-modifying treatments for a broad range of ...

Evotec and Celgene enter into strategic oncology partnership

22-May-2018 - Evotec AG announced that Evotec and Celgene Corporation have entered into a long-term strategic drug discovery and development partnership to identify new therapeutics in oncology. Evotec has built one of the industry's broadest and most innovative pre-clinical discovery and development ...

biotechnology Celgene collaborations +4

Evotec and Celgene collaborate in drug discovery for neurogenerative diseases

16-Dec-2016 - Evotec AG announced that Evotec and Celgene Corporation have entered into a strategic drug discovery and development collaboration to identify disease-modifying therapeutics for a broad range of neurodegenerative diseases. Initial disease areas of focus will include Amyotrophic lateral sclerosis, ...

Celgene collaborations drug discovery +3

Celgene to Acquire Receptos

16-Jul-2015 - Celgene Corporation and Receptos, Inc. announced the signing of a definitive agreement in which Celgene has agreed to acquire Receptos. Under the terms of the merger agreement, Celgene will pay $232.00 per share in cash, or a total of approximately $7.2 billion, net of cash acquired. The ...

acquisitions Celgene

Celgene Completes Acquisition of Abraxis

19-Oct-2010 - Celgene Corporation announced it has completed its acquisition of Abraxis BioScience, Inc. For each share of Abraxis common stock, Abraxis shareholders will receive $58.00 in cash, 0.2617 shares of Celgene common stock, and one tradeable Contingent Value Right (CVR), which entitles its holder to ...

albumin Celgene oncology +1

Innate Pharma initiates collaboration with Celgene to evaluate the clinical potential of REVLIMID combined with IPH 2101

19-Nov-2009 - Innate Pharma announced that Celgene Corporationhas agreed to collaborate with Innate Pharma to evaluate the potential clinical synergy of the combination treatment regimen of lenalidomide (REVLIMID®) plus IPH 2101 in patients with multiple myeloma (“MMy”) who have failed first-line therapy. The ...

Celgene clinical trials lenalidomide +2

Celgene Announces New Drug Application Filing for REVLIMID in Japan

08-Jul-2009 - Celgene International Sàrl announced it has filed a New Drug Application (NDA) with the Japanese Ministry of Health, Labour and Welfare (MHLW) for REVLIMID (lenalidomide) in combination with dexamethasone for the treatment of patients with multiple myeloma who have received at least one prior ...

anaemia Celgene lenalidomide +6